CMS will pay for booster COVID shots for the immunocompromised
On Aug. 12, the Food and Drug Administration (FDA) revised the emergency use authorizations (EUA) for the Pfizer and Moderna COVID-19 vaccines, approving booster shots for immunocompromised individuals, and CMS later announced it would cover the extra shots.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.